4,000
Participants
Start Date
December 20, 2024
Primary Completion Date
July 31, 2026
Study Completion Date
July 31, 2026
Remote study participation and self-collection of specimens
Participants in Group B will complete all study procedures remotely and will not physically visit any clinical research site. This will include telehealth (videoconference) visits with study personnel, self-collection of specimens, shipping of specimens using pre-labeled packaging, and completion of electronic diaries for data collection.
Traditional clinical trial participation with clinician-collected specimens
Participants in Group A will attend study visits in person at a clinical research site and will have the majority of specimens collected by a clinician at the clinic. Group A participants will have some electronic diary usage.
SUNY / Upstate Medical University Global Health Institute, Syracuse
Emory University, Atlanta
Wake Research Atlanta, Atlanta
Research Institute of South Florida, Miami
Accel Research Site Networks - Birmingham CRU / Elite, Vestavia Hills
Research Integrity / WCG, Owensboro
Kroger The Little Clinic (Remote Site), Blue Ash
Johnson County Clinical Trials (JCCT), Lenexa
Be Well Clinical Studies / Elite, Lincoln
Lynn Health Science Institute East / Elite, Oklahoma City
Wake Research Dallas, Dallas
Desert Clinical Research, Mesa
Wake Research Encino, Los Angeles
Wake Research San Diego, San Diego
Apex Research Group, Fair Oaks
Alcanza / hyperCORE, Boston
Collaborators (1)
Fred Hutchinson Cancer Center
OTHER
Allucent
UNKNOWN
Biomedical Advanced Research and Development Authority
FED